Search
Search Results
-
Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities
BackgroundGlucagon-like peptide-1 (GLP-1) analogs are approved for the treatment of obesity in adults and adolescents. Reports have emerged that the...
-
Insulin-like peptide 5 (INSL5) positively correlates with anti-Müllerian hormone (AMH) in women with the polycystic ovary syndrome: a case-control study
BackgroundInsulin-like peptide 5 (INSL5) is involved in both reproductive and metabolic processes in polycystic ovary syndrome (PCOS). This study...
-
Suboptimal Weight Loss 13 Years After Roux-en-Y Gastric Bypass Is Associated with Blunted Appetite Response
PurposeBariatric surgery remains the most efficient treatment to achieve a sustained weight loss. However, a large proportion of patients experience...
-
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
PurposeWeight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of...
-
The role of body composition and appetite-regulating hormones in idiopathic central precocious puberty and their changes during GnRH analog therapy
PurposeIt was aimed to compare circulating levels of ghrelin, leptin, peptide YY (PYY), and neuropeptide (NPY) between girls with idiopathic central...
-
The Clinicopathological Significance of Tumor Cell Subty** in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors
Appendiceal neuroendocrine tumors (NETs) are common and often are identified as incidental lesions at the time of appendectomy. The guidelines for...
-
Association Between Gut Hormones and Weight Change After Bariatric Arterial Embolization: Results from the BEAT Obesity Trial
PurposeTo evaluate associations of ghrelin, glucagon-like peptide 1 (GLP-1), and peptide YY 3–36 (PYY3-36) with weight change after bariatric...
-
Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake
Background/ObjectivesAfter Roux-en-Y gastric bypass (RYGB) a subset of patients never obtain excess BMI loss (EBMIL) > 50% and are categorized as...
-
The role of insufficient sleep and circadian misalignment in obesity
Traditional risk factors for obesity and the metabolic syndrome, such as excess energy intake and lack of physical activity, cannot fully explain the...
-
Gastric Aspiration Improves Postprandial Glucose Tolerance Without Causing a Compensatory Increase in Appetite and Food Intake
IntroductionAspireAssist® allows aspiration of ~30% of an ingested meal through a percutaneous gastrostomy tube, reducing caloric uptake. We...
-
Effect of inulin on breath hydrogen, postprandial glycemia, gut hormone release, and appetite perception in RYGB patients: a prospective, randomized, cross-over pilot study
Background and objectiveLarge intestinal fermentation of dietary fiber may control meal-related glycemia and appetite via the production of...
-
The Effect of Antrum Size on Weight Loss, Glucagon-Like Peptide-1 (GLP-1) Levels, and Glycemic Control Following Laparoscopic Sleeve Gastrectomy in Adolescents with Obesity and Type 2 Diabetes
PurposeThe aim of this study was to compare the effect of antral resection versus antral preservation sleeve gastrectomy on the post-operative GLP-1,...
-
Differences in cognition, short-chain fatty acids and related metabolites in pregnant versus non-pregnant women: a cross-sectional study
BackgroundPregnancy induces cognitive reorganization which can lead to mental disorders. The aim of this study is to determine differences in...
-
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists
Obesity is a chronic disease associated with many complications. Weight loss of 5–15% can improve many obesity-related complications. Despite the...
-
Change in Adipokines and Gastrointestinal Hormones After Bariatric Surgery: a Meta-analysis
PurposeThe study aimed to perform a meta-analysis about the change in adipokines and gastrointestinal hormones after bariatric surgery in patients...
-
Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature
Ghrelin, glucagon-like peptide-1 (GLP-1), and peptide YY (PYY) are involved in energy balance regulation and glucose homeostasis. Obesity is...
-
The acute effect of fasted exercise on energy intake, energy expenditure, subjective hunger and gastrointestinal hormone release compared to fed exercise in healthy individuals: a systematic review and network meta-analysis
ObjectiveTo determine the acute effect of fasted and fed exercise on energy intake, energy expenditure, subjective hunger and gastrointestinal...
-
Diabetes Remission After LRYGBP With and Without Fundus Resection: a Randomized Clinical Trial
BackgroundGlycemic control, after metabolic surgery, is achieved in two stages, initially with neuroendocrine alterations and in the long-term with...
-
Targeting the incretin system in obesity and type 2 diabetes mellitus
Obesity and type 2 diabetes mellitus (T2DM) are widespread, non-communicable diseases that are responsible for considerable levels of morbidity and...
-
Effect of acupuncture on serum PYY and nesfatin-1 in obese patients with insulin resistance
ObjectiveTo observe the effect of acupuncture on serum peptide YY (PYY) and nesfatin-1 in obese patients with insulin resistance.
Methods ...